HeartCore Reports Full Year 2023 EPS $(0.21) Vs $(0.37) YoY; Revenue $21.85M Vs $8.82M YoY

Full Year 2023 Financial Results

Revenues increased 147.7% to $21.8 million compared to $8.8 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

Gross profit increased 140.7% to $8.1 million from $3.4 million in the same period last year. The increase was primarily due to an increase in Go IPO consulting service revenues and received warrants from customers, and an increase from customized software development and services as a result of Sigmaways and its subsidiaries.

Operating expenses increased to $12.2 million from $10.0 million in the same period last year. The increase was primarily due to increases in general and administrative expenses and research and development expenses, offset by a decrease in selling expenses.

Net loss was about $4.9 million or $(0.21) per diluted share compared to a net loss of $6.7 million or $(0.37) per diluted share, in the same period last year.

As of December 31, 2023, the Company had cash and cash equivalents of $1.0 million compared to $7.2 million in December 31, 2022.